Back to Search
SAPNA LEGHA, MD
MD
Cardiovascular Disease Physician
NPI: 1073899506IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
S6670(TX)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 2005
Research & Publications (10)
Treating metastatic melanoma: further considerations.
PMID 19544691·Oncology (Williston Park)·2009
8-other
A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence.
PMID 19430405·Melanoma Res·2009
3-trial
Multicenter phase III randomized trial of polychemotherapy (CVD regimen) versus the same chemotherapy (CT) plus subcutaneous interleukin-2 and interferon-alpha2b in metastatic melanoma.
PMID 16469753·Ann Oncol·2006
3-trial
A phase II open-label trial of apomine (SR-45023A) in patients with refractory melanoma.
PMID 16379038·Invest New Drugs·2006
3-trial
Phase II study of thalidomide in patients with metastatic melanoma.
PMID 15091195·Melanoma Res·2004
3-trial
Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma.
PMID 12115326·Cancer·2002
3-trial
Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel.
PMID 12006516·Clin Cancer Res·2002
3-trial
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.
PMID 11956264·J Clin Oncol·2002
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 17189 INTERSTATE 45 S STE 475
SHENANDOAH, TX 77385 - Phone
- (936) 270-3933
Quick Facts
- NPI
- 1073899506
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 21
- Publications
- 10
Are you this provider?
Claim Your Profile